Objective: We sought to evaluate the efficacy and safety of vildagliptin, a new dipeptidyl peptidase-4 inhibitor, added to metformin during 24 weeks of treatment in patients with type 2 diabetes.

of Dapagliflozin, Sitagliptin and Metformin under the brand name of Dapanorm Trio ® at an affordable price for adults with Type 2 Diabetes in India. Speaking on the launch of Dapanorm Trio ...

After excluding patients with a range of pre-existing conditions, a history of gastric surgery, and those taking weight loss drugs, participants were randomly assigned to either moderate calorie ...

In the group receiving 100 mg vildagliptin daily and continuing metformin treatment, more than three-quarters of patients experienced a meaningful (41.3%) or marked (37.1%) improvement in glycemic ...